Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05071586 · ClinicalTrials.gov registry record · NA

Pediatric Teleneuromodulation

A NA study of Cerebral Palsy (CP), sponsored by University of Wisconsin, Madison.

Completed
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT05071586 is a NA study of Cerebral Palsy (CP) that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 10 participants, below the 29-participant average among 7 other Cerebral Palsy (CP) trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05071586, a NA study of Cerebral Palsy (CP), has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

This study will explore using remotely monitored 'active' non-invasive brain stimulation in children with cerebral palsy. Participants will receive active non-invasive brain stimulation with synchronous safety monitoring and guided instruction with laboratory staff after appropriate training. Participants will be between 8-21 years old and have a diagnosis of hemiparetic cerebral palsy with a history of a perinatal stroke or brain bleed, and can expect to be in the study for 5 days.

Conditions Studied

Interventions

  • DEVICE Soterix 1x1 tDCS LTE Stimulator Device Model 1401

Study Locations (1)

Wisconsin

  • University of Wisconsin - Madison

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2022-12-21
Est. Completion 2023-06-06
Phase NA

Sponsor

University of Wisconsin, Madison

1,039 total trials

What the Registry Record Tells You About NCT05071586

The ClinicalTrials.gov registry entry for NCT05071586 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 29-participant average among 7 other Cerebral Palsy (CP) trials with a reported enrollment target (66% lower). The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cerebral Palsy (CP) appearing as the primary indexed condition, and to 1 intervention - of which Soterix 1x1 tDCS LTE Stimulator Device Model 1401 is the first listed.

NCT05071586 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT05071586 about?

NCT05071586 is a clinical study titled "Pediatric Teleneuromodulation". This study will explore using remotely monitored 'active' non-invasive brain stimulation in children with cerebral palsy. Participants will receive active non-invasive brain stimulation with synchronous safety monitoring and guided instruction with laboratory staff after appropriate training. Partic...

What is the current status of trial NCT05071586?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2022-12-21. Estimated completion is 2023-06-06.

What conditions does trial NCT05071586 study?

This clinical trial studies the following conditions: Cerebral Palsy (CP).

What interventions are being tested in trial NCT05071586?

The interventions under investigation include: Soterix 1x1 tDCS LTE Stimulator Device Model 1401 (DEVICE).

Who is sponsoring clinical trial NCT05071586?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05071586 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cerebral Palsy (CP)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.